Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.54
0.133.07%
Ult. Agg.: Oct 30, 4:59 PM
Market sentiment signals for Entrada Therapeutics (TRDA): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
5 analysts
Options Flow (P/C)
—
Avg Consensus PT
$23
+395.6%
Highest Price Target
$29
+531.8%
Lowest Price Target
$17
+270.4%
Short Interest
13.0%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Guggenheim | Debjit Chattopadhyay— | +270.4% | $20 → $17 | Maintained | Buy |
| May 8, 2026 | HC Wainwright & Co. | Raghuram Selvaraju— | — | — | Downgrade | Buy→Neutral |
